Biolase Inc

NASDAQ:BIOL  
0.67
+0.02 (+3.34%)
Other Pre-Announcement

Biolase Reports Significantly Improved Revenue In Its Second Quarter As Continued High Demand For Dental Lasers From New Customers Fueled Growth

Published: 08/12/2021 22:16 GMT
Biolase Inc (BIOL) - Biolase Reports Significantly Improved Revenue in Its Second Quarter As Continued High Demand for Dental Lasers From New Customers Fueled Growth.
Q2 Earnings per Share $0.00.
Q2 Earnings per Share Estimate $-0.04 -- Refinitiv Ibes Data (analyst estimates).
Q2 Revenue $9.1 Million Versus Refinitiv Ibes Estimate of $8.3 Million.
Continues to Experience High Demand for Its Dental Lasers.
Currently Forecasting Revenue for Q3 to Be Significantly Above Year-ago Q3.
Expect Q3 of 2021 to Approach Revenues Achieved in Q2 of 2021.